Erythropoietin-resistant refractory renal anemia: effects of oral L-carnitine supplementation
Current shortage status of GLP-1 products (as of October 02, 2024): Tirzepatide injection: Shortage resolved
If using tirzepatide, women should discuss contraception, as backup methods are recommended during initiation and for 4 weeks after dose increases
In the case of Ozempic, off-label use for weight loss is closely related to its sister medication Wegovy, which contains the same active ingredient (semaglutide) but is approved specifically for obesity at a higher dose
An IV, on the other hand, delivers the antioxidant straight to the bloodstream
Some report decreased appetite, others increased hunger